These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19607806)

  • 1. CCL5 promotes proliferation of MCF-7 cells through mTOR-dependent mRNA translation.
    Murooka TT; Rahbar R; Fish EN
    Biochem Biophys Res Commun; 2009 Sep; 387(2):381-6. PubMed ID: 19607806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.
    Zhang Y; Yao F; Yao X; Yi C; Tan C; Wei L; Sun S
    Oncol Rep; 2009 Apr; 21(4):1113-21. PubMed ID: 19288016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide in physiologic concentrations targets the translational machinery to increase the proliferation of human breast cancer cells: involvement of mammalian target of rapamycin/eIF4E pathway.
    Pervin S; Singh R; Hernandez E; Wu G; Chaudhuri G
    Cancer Res; 2007 Jan; 67(1):289-99. PubMed ID: 17210710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCL5/CCR5 axis promotes the motility of human oral cancer cells.
    Chuang JY; Yang WH; Chen HT; Huang CY; Tan TW; Lin YT; Hsu CJ; Fong YC; Tang CH
    J Cell Physiol; 2009 Aug; 220(2):418-26. PubMed ID: 19334035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells.
    Dowling RJ; Zakikhani M; Fantus IG; Pollak M; Sonenberg N
    Cancer Res; 2007 Nov; 67(22):10804-12. PubMed ID: 18006825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CCL5 (RANTES) and CCR5 in prostate cancer.
    Vaday GG; Peehl DM; Kadam PA; Lawrence DM
    Prostate; 2006 Feb; 66(2):124-34. PubMed ID: 16161154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of down-regulation of CC chemokine ligand 5 (CCL5) on proliferation of human breast cancer cells in vitro].
    Kuang JX; Wang WX; Sun SR; Wang WR; Yao XL
    Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):174-7. PubMed ID: 21575514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Myc and eIF4F are components of a feedforward loop that links transcription and translation.
    Lin CJ; Cencic R; Mills JR; Robert F; Pelletier J
    Cancer Res; 2008 Jul; 68(13):5326-34. PubMed ID: 18593934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chemokine CCL5 regulates the in vivo cell surface expression of its receptor, CCR5.
    Lin YL; Mettling C; Portalès P; Rouzier R; Clot J; Reynes J; Corbeau P
    AIDS; 2008 Jan; 22(3):430-2. PubMed ID: 18195571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL5 activation of CCR5 regulates cell metabolism to enhance proliferation of breast cancer cells.
    Gao D; Rahbar R; Fish EN
    Open Biol; 2016 Jun; 6(6):. PubMed ID: 27335323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCL5-mediated T-cell chemotaxis involves the initiation of mRNA translation through mTOR/4E-BP1.
    Murooka TT; Rahbar R; Platanias LC; Fish EN
    Blood; 2008 May; 111(10):4892-901. PubMed ID: 18337562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer cell CCL5 mediates bone marrow independent angiogenesis in breast cancer.
    Sax MJ; Gasch C; Athota VR; Freeman R; Rasighaemi P; Westcott DE; Day CJ; Nikolic I; Elsworth B; Wei M; Rogers K; Swarbrick A; Mittal V; Pouliot N; Mellick AS
    Oncotarget; 2016 Dec; 7(51):85437-85449. PubMed ID: 27863423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoma-associated eIF3i overexpression facilitates mTOR-dependent growth transformation.
    Ahlemann M; Zeidler R; Lang S; Mack B; Münz M; Gires O
    Mol Carcinog; 2006 Dec; 45(12):957-67. PubMed ID: 16929481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells.
    Neubauer H; Adam G; Seeger H; Mueck AO; Solomayer E; Wallwiener D; Cahill MA; Fehm T
    Climacteric; 2009 Jun; 12(3):230-9. PubMed ID: 19340614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCL5-CCR5 interactions modulate metabolic events during tumor onset to promote tumorigenesis.
    Gao D; Cazares LH; Fish EN
    BMC Cancer; 2017 Dec; 17(1):834. PubMed ID: 29216863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
    Girgert R; Hanf V; Emons G; Gründker C
    J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine C-C motif receptor 5 and C-C motif ligand 5 promote cancer cell migration under hypoxia.
    Lin S; Wan S; Sun L; Hu J; Fang D; Zhao R; Yuan S; Zhang L
    Cancer Sci; 2012 May; 103(5):904-12. PubMed ID: 22380870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro pharmacoregulation of CC chemokine ligand 5 and its receptor CCR5 in diffuse lung diseases.
    Sekerova V; Subrtova D; Mrazek F; Gibejova A; Kolek V; du Bois RM; Petrek M
    Mediators Inflamm; 2003 Aug; 12(4):215-20. PubMed ID: 14514472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of neferine on CCL5 and CCR5 expression in SCG of type 2 diabetic rats.
    Li G; Xu H; Zhu S; Xu W; Qin S; Liu S; Tu G; Peng H; Qiu S; Yu S; Zhu Q; Fan B; Zheng C; Li G; Liang S
    Brain Res Bull; 2013 Jan; 90():79-87. PubMed ID: 23063706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SKAR links pre-mRNA splicing to mTOR/S6K1-mediated enhanced translation efficiency of spliced mRNAs.
    Ma XM; Yoon SO; Richardson CJ; Jülich K; Blenis J
    Cell; 2008 Apr; 133(2):303-13. PubMed ID: 18423201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.